Sapience Investments’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.4K | Sell |
787
-26,636
| -97% | -$482K | 2.38% | 5 |
|
|
2025
Q4 | $389K | Buy |
27,423
+4,845
| +21% | +$91.7K | 1.47% | 45 |
|
|
2025
Q3 | $559K | Sell |
22,578
-98,267
| -81% | -$2.19M | 2.19% | 21 |
|
|
2025
Q2 | $2.74M | Buy |
120,845
+35,797
| +42% | +$848K | 1.83% | 13 |
|
|
2025
Q1 | $2.58M | Buy |
85,048
+6,163
| +8% | +$235K | 1.84% | 11 |
|
|
2024
Q4 | $3.13M | Buy |
78,885
+31,056
| +65% | +$1.4M | 1.83% | 12 |
|
|
2024
Q3 | $3.03M | Sell |
47,829
-14,183
| -23% | -$1.02M | 1.5% | 25 |
|
|
2024
Q2 | $4.19M | Buy |
62,012
+5,329
| +9% | +$372K | 2.14% | 5 |
|
|
2024
Q1 | $4.49M | Sell |
56,683
-30,410
| -35% | -$2.49M | 1.49% | 34 |
|
|
2023
Q4 | $6.77M | Sell |
87,093
-14,880
| -15% | -$1.1M | 1.61% | 27 |
|
|
2023
Q3 | $7.17M | Sell |
101,973
-2,972
| -3% | -$222K | 1.72% | 24 |
|
|
2023
Q2 | $8.36M | Sell |
104,945
-1,235
| -1% | -$89.2K | 1.88% | 21 |
|
|
2023
Q1 | $7.67M | Buy |
106,180
+35,700
| +51% | +$2.78M | 1.77% | 22 |
|
|
2022
Q4 | $5.8M | Sell |
70,480
-8,155
| -10% | -$672K | 1.22% | 44 |
|
|
2022
Q3 | $6.15M | Sell |
78,635
-19,970
| -20% | -$1.6M | 1.29% | 41 |
|
|
2022
Q2 | $6.67M | Sell |
98,605
-65,190
| -40% | -$4.55M | 1.25% | 44 |
|
|
2022
Q1 | $10.7M | Sell |
163,795
-15,540
| -9% | -$903K | 1.3% | 41 |
|
|
2021
Q4 | $10.9M | Sell |
179,335
-3,750
| -2% | -$224K | 1.24% | 47 |
|
|
2021
Q3 | $11.7M | Buy |
183,085
+14,960
| +9% | +$944K | 1.39% | 40 |
|
|
2021
Q2 | $10.6M | Sell |
168,125
-5,640
| -3% | -$354K | 1.31% | 39 |
|
|
2021
Q1 | $9.93M | Sell |
173,765
-21,420
| -11% | -$1.16M | 1.25% | 42 |
|
|
2020
Q4 | $9.81M | Sell |
195,185
-131,975
| -40% | -$5.26M | 1.36% | 33 |
|
|
2020
Q3 | $9.64M | Buy |
327,160
+2,300
| +0.7% | +$66.8K | 1.71% | 15 |
|
|
2020
Q2 | $8.16M | Sell |
324,860
-47,500
| -13% | -$1.19M | 1.5% | 22 |
|
|
2020
Q1 | $6.83M | Buy |
372,360
+24,950
| +7% | +$714K | 1.52% | 23 |
|
|
2019
Q4 | $11.5M | Buy |
347,410
+39,830
| +13% | +$1.25M | 1.61% | 19 |
|
|
2019
Q3 | $9.56M | Buy |
307,580
+46,483
| +18% | +$1.42M | 1.33% | 29 |
|
|
2019
Q2 | $9.13M | Sell |
261,097
-1,442
| -0.5% | -$46.6K | 1.24% | 31 |
|
|
2019
Q1 | $7.7M | Buy |
262,539
+13,479
| +5% | +$382K | 1.02% | 41 |
|
|
2018
Q4 | $6.4M | Buy |
249,060
+16,280
| +7% | +$563K | 1.04% | 44 |
|
|
2018
Q3 | $8.19M | Buy |
232,780
+76,850
| +49% | +$3.06M | 1% | 51 |
|
|
2018
Q2 | $6.38M | Sell |
155,930
-35,883
| -19% | -$1.45M | 0.84% | 56 |
|
|
2018
Q1 | $7.51M | Sell |
191,813
-123,197
| -39% | -$4.52M | 1.03% | 48 |
|
|
2017
Q4 | $10.3M | Buy |
+315,010
| New | +$10.9M | 1.39% | 29 |
|
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
Sapience Investments's ACHC Position: Q1 2026 in Review
Sapience Investments reduced its Acadia Healthcare (ACHC) stake by 97% in Q1 2026, selling an estimated $482K and leaving 787 shares worth $18.4K. The position accounts for 2.38% of the portfolio, ranked #5.
Sapience Investments first reported a position in ACHC in Q4 2017 and has held it in 34 quarters since. The position peaked at $11.7M in Q3 2021. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- Sapience Investments held 787 shares of Acadia Healthcare worth $18.4K as of Q1 2026.
- Sapience Investments sold 26,636 Acadia Healthcare shares in Q1 2026, an estimated $482K.
- Acadia Healthcare made up 2.38% of Sapience Investments's portfolio in Q1 2026, its #5 holding.
- Sapience Investments first reported a position in Acadia Healthcare in Q4 2017 and has held it in 34 quarters since.
- Sapience Investments's Acadia Healthcare position peaked at $11.7M in Q3 2021.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on Sapience Investments's 13F filing for Q1 2026, filed 15 May 2026.